drugset / Trial / NCT00231075

Evaluation of the Safety and Efficacy of Paraplatin in Combination With Taxol in Patients of 70 Years and Older With Ovary Cancer F.I.G.O. Stages III-IV

NCT00231075 ↗

Phase 2 Completed 75 enrolled ARCAGY/ GINECO GROUP
Non-randomizedSingle-groupOpen-labelTreatment

Summary

Safety and Efficacy of Paraplatin in combination with Taxol in patients of 70 years or older with epithelial ovary cancer F.I.G.O. stages III and IV.

Timeline

Start
2001-01
Primary completion
—
Completion
2007-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Carboplatin Small molecule — —
Subject Paclitaxel Small molecule — —

Indications